NIDAN — Nidan Laboratories and Healthcare Share Price
Last trade - 00:00- IN₹441.33m
- IN₹471.11m
- IN₹242.66m
- 57
- 69
- 23
- 47
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.62 | ||
| Price to Tang. Book | 0.62 | ||
| Price to Free Cashflow | 20.61 | ||
| Price to Sales | 2.01 | ||
| EV to EBITDA | 2.31 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 22.85% | ||
| Return on Equity | 4.48% | ||
| Operating Margin | 79.23% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 209.72 | 221.92 | 203.78 | 296.6 | 242.66 | n/a | n/a | 3.71% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +219.73 | +222.21 | +31.23 | +10.59 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Nidan Laboratories and Healthcare Limited is a diagnostic imaging center operator, which is engaged in providing diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. It provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to advanced radiology tests, including computerized tomography (CT) scans, magnetic resonance imaging (MRI) scans. The Company also offers a spectrum of customized health and wellness packages and value-added services to its customers, such as a home collection of specimens, house calls, and various delivery or access modes for test reports. The Company's tests area covers different age groups from offerings for prenatal screening to screening for hormonal imbalance, nutritional deficiencies and tracking lifestyle disorders.
Directors
- Last Annual
- March 31st, 2023
- Last Interim
- September 30th, 2023
- Incorporated
- December 5th, 2000
- Public Since
- November 12th, 2021
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 13,900,000
- Address
- Swapnshilpa, PALGHAR, 401303
- Web
- http://www.nidanhealthcare.co.in/
- Phone
- +91 2502500004
- Auditors
- R. K. Chapawat & Co.
Similar to NIDAN
Aatmaj Healthcare
National Stock Exchange of India
Apollo Hospitals Enterprise
National Stock Exchange of India
Artemis Medicare Services
National Stock Exchange of India
Aster DM Healthcare
National Stock Exchange of India
Dr. Lal PathLabs
National Stock Exchange of India
FAQ
As of Today at 19:15 UTC, shares in Nidan Laboratories and Healthcare are trading at IN₹31.75. This share price information is delayed by 15 minutes.
Shares in Nidan Laboratories and Healthcare last closed at IN₹31.75 and the price had moved by -29.05% over the past 365 days. In terms of relative price strength the Nidan Laboratories and Healthcare share price has underperformed the S&P BSE 100 Index by -44.88% over the past year.
There is no consensus recommendation for this security.
Nidan Laboratories and Healthcare does not currently pay a dividend.
Nidan Laboratories and Healthcare does not currently pay a dividend.
Nidan Laboratories and Healthcare does not currently pay a dividend.
To buy shares in Nidan Laboratories and Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹31.75, shares in Nidan Laboratories and Healthcare had a market capitalisation of IN₹441.33m.
Here are the trading details for Nidan Laboratories and Healthcare:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: NIDAN
Based on an overall assessment of its quality, value and momentum Nidan Laboratories and Healthcare is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Nidan Laboratories and Healthcare. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -18.2%.
As of the last closing price of IN₹31.75, shares in Nidan Laboratories and Healthcare were trading -8.42% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Nidan Laboratories and Healthcare PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹31.75.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Nidan Laboratories and Healthcare's directors